These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation. Rai AK; Panda M; Das AK; Rahman T; Das R; Das K; Sarma A; Kataki AC; Chattopadhyay I Arch Microbiol; 2021 Jan; 203(1):137-152. PubMed ID: 32783067 [TBL] [Abstract][Full Text] [Related]
3. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma. Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690 [TBL] [Abstract][Full Text] [Related]
4. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis. Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791 [TBL] [Abstract][Full Text] [Related]
5. TUSC3, p53 and p21 genetic association with development of oral submucous fibrosis and oral squamous cell carcinoma among addictive tobacco chewers of Pakistan. Zaidi SAA; Chughtai N; Abbassi ZA; Alam J; Malick TS; Salim A; Saleem S BMC Oral Health; 2024 Jul; 24(1):780. PubMed ID: 38992585 [TBL] [Abstract][Full Text] [Related]
6. Oral submucous fibrosis transforming into squamous cell carcinoma: a prospective study over 31 years in mainland China. Jian X; Jian Y; Wu X; Guo F; Hu Y; Gao X; Jiang C; Li N; Wu Y; Liu D Clin Oral Investig; 2021 Apr; 25(4):2249-2256. PubMed ID: 32844258 [TBL] [Abstract][Full Text] [Related]
7. Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment. Zhi Y; Wang Q; Zi M; Zhang S; Ge J; Liu K; Lu L; Fan C; Yan Q; Shi L; Chen P; Fan S; Liao Q; Guo C; Wang F; Gong Z; Xiong W; Zeng Z Adv Sci (Weinh); 2024 Mar; 11(12):e2306515. PubMed ID: 38229179 [TBL] [Abstract][Full Text] [Related]
8. Compositional and functional changes in the salivary microbiota related to oral leukoplakia and oral squamous cell carcinoma: a case control study. Lan Q; Zhang C; Hua H; Hu X BMC Oral Health; 2023 Dec; 23(1):1021. PubMed ID: 38115005 [TBL] [Abstract][Full Text] [Related]
9. Multiple logistic regression analysis of risk factors for carcinogenesis of oral submucous fibrosis in mainland China. Zhou S; Guo F; Li L; Zhou Y; Lei Y; Hu Y; Su H; Chen X; Yin P; Jian X Int J Oral Maxillofac Surg; 2008 Dec; 37(12):1094-8. PubMed ID: 18684592 [TBL] [Abstract][Full Text] [Related]
10. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma. Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276 [TBL] [Abstract][Full Text] [Related]
11. An Evaluation of Clinical and Histopathological Aspects of Patients with Oral Submucous Fibrosis in the Background of Oral Squamous Cell Carcinoma. Siriwardena BSMS; Jayawardena KLTD; Senarath NH; Tilakaratne WM Biomed Res Int; 2018; 2018():4154165. PubMed ID: 30402477 [TBL] [Abstract][Full Text] [Related]
12. Taxonomic and Functional Dysregulation in Salivary Microbiomes During Oral Carcinogenesis. Chen JW; Wu JH; Chiang WF; Chen YL; Wu WS; Wu LW Front Cell Infect Microbiol; 2021; 11():663068. PubMed ID: 34604102 [TBL] [Abstract][Full Text] [Related]
13. Skewed Th17/Treg balance during progression and malignant transformation of oral submucous fibrosis. Liu S; Liu Z; Shan Z; Liu Y; Chen T; Fang L; Quan H Oral Dis; 2022 Nov; 28(8):2119-2130. PubMed ID: 33749974 [TBL] [Abstract][Full Text] [Related]
14. Oral microbiota alteration associated with oral cancer and areca chewing. Zhong X; Lu Q; Zhang Q; He Y; Wei W; Wang Y Oral Dis; 2021 Mar; 27(2):226-239. PubMed ID: 32649007 [TBL] [Abstract][Full Text] [Related]
15. On the Oral Microbiome of Oral Potentially Malignant and Malignant Disorders: Dysbiosis, Loss of Diversity, and Pathogens Enrichment. Herreros-Pomares A; Hervás D; Bagan-Debón L; Jantus-Lewintre E; Gimeno-Cardona C; Bagan J Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834903 [TBL] [Abstract][Full Text] [Related]
16. Relation of salivary MMP-8 with oral submucous fibrosis and oral squamous cell carcinoma: a cross sectional analytical study. Kazmi A; Abbas Z; Saleem Z; Haider S; Farooqui WA; Ahmed S BMJ Open; 2022 Dec; 12(12):e060738. PubMed ID: 36523229 [TBL] [Abstract][Full Text] [Related]
17. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis. Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428 [TBL] [Abstract][Full Text] [Related]
18. The prevalence of oral squamous cell carcinoma with oral submucous fibrosis. Saalim M; Sansare K; Karjodkar FR; Johaley S; Ali IK; Sharma SR; Mehra A; Rahman B J Cancer Res Ther; 2021; 17(6):1510-1514. PubMed ID: 34916386 [TBL] [Abstract][Full Text] [Related]
19. Change and pathological significance of glycogen content in oral squamous cell carcinoma and oral submucous fibrosis. Nie H; Hu X; Xiong H; Zeng L; Chen W; Su T Tissue Cell; 2024 Apr; 87():102337. PubMed ID: 38430849 [TBL] [Abstract][Full Text] [Related]
20. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis. Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]